| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Revance Therapeutics, Inc. | Chief Commercial Officer | Common Stock | 0 | $0 | $3.65 | 06 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000095017025015356-jordan-erica-2025-02-04 | Revance Therapeutics, Inc. | 04 Feb 2025 | 2 | -$25,265 | 4 | Chief Commercial Officer | 06 Feb 2025, 15:57 |
| /report/000147929024000074-jordan-erica-2024-04-16 | Revance Therapeutics, Inc. | 16 Apr 2024 | 1 | -$9,096 | 4 | Chief Commercial Officer | 17 Apr 2024, 16:34 |
| /report/000147929024000045-jordan-erica-2024-02-27 | Revance Therapeutics, Inc. | 27 Feb 2024 | 0 | $0 | 3 | Chief Commercial Officer | 29 Feb 2024, 16:36 |